Skip to main content

Thioredoxin, a novel agent for mitigating radiation-induced hematopoietic injury

Research Grant
Duke Scholars

Administered By

Medicine, Hematologic Malignancies and Cellular Therapy

Awarded By

National Institutes of Health

Start Date

September 9, 2022

End Date

August 31, 2023
 

Administered By

Medicine, Hematologic Malignancies and Cellular Therapy

Awarded By

National Institutes of Health

Start Date

September 9, 2022

End Date

August 31, 2023